- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- DOSAGE AND ADMINISTRATION
- DECAY CHART
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
P32 SODIUM PHOSPHATE
p32 sodium phosphate injection, suspensionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51808-127 Route of Administration INTRA-ARTICULAR, INTRAPERITONEAL, INTERSTITIAL, INTRAPLEURAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHOSPHORUS P-32 (UNII: 690284A407) (PHOSPHORUS P-32 - UNII:690284A407) PHOSPHORUS P-32 5 mCi in 1 mL Inactive Ingredients Ingredient Name Strength DEXTROSE (UNII: IY9XDZ35W2) 0.3 g in 1 mL BENZYL ALCOHOL (UNII: LKG8494WBH) 0.02 mL in 1 mL SODIUM ACETATE (UNII: 4550K0SC9B) 1 mg in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:51808-127-01 3 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 06/19/2012 Labeler - AnazaoHealth Corporation (011038762) Establishment Name Address ID/FEI Business Operations AnazaoHealth Corporation 011038762 MANUFACTURE(51808-127)